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Abstract SNI-2011 induces the long-lasting increase in the
amount of aquaporin-5 (AQP5) in apical plasma membranes
(APMs) of rat parotid acini in a concentration-dependent
manner. This induction was inhibited by p-F-HHSiD, U73122,
TMB-8, or dantrolene but not by bisindolmaleimide or H-7,
indicating that SNI-2011 acting at M3 muscarinic receptors
induced translocation of AQP5 via [Ca2+]i elevation but not
via the activation of protein kinase C. In contrast, acetyl-
choline induced a transient translocation of AQP5 to APMs.
SNI-2011 induces long-lasting oscillations of [Ca2+]i in the
presence of extracellular Ca2+. Thus, SNI-2011 induces a long-
lasting translocation of AQP5 to APMs coupled with persistent
[Ca2+]i oscillations. ß 2000 Federation of European Biochem-
ical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
Aquaporin proteins (AQPs), which form water channels,
have been cloned from a variety of mammalian tissues [1^4].
In several non-excitable cell types, the function of AQPs is
regulated by the interaction of hormones or neurotransmitters
with their speci¢c receptors. AQP1 in rat bile duct cells and
AQP2 in rat renal collecting duct cells were transferred from
the intracellular membrane (ICM) to the plasma membrane in
response to secretin [5] and vasopressin [6,7], respectively,
with a simultaneous increase in £uid transport. While we
demonstrated that AQP5, which was cloned from rat subman-
dibular glands [8], was transferred from the ICM to the apical
plasma membrane (APM) in response to acetylcholine (ACh)
or epinephrine via the activation of M3 muscarinic receptors
(M3AChRs) or K1-adrenergic receptors on the basolateral
membrane (BLM), respectively [9,10]. Moreover, the mainte-
nance of AQP5 in the APM was transient in parotid glands
stimulated by ACh or epinephrine with a maximum at 15 s or
1 min, respectively.
The condition of xerostomia is characterized by oral dry-
ness and di⁄culty in performing oral functions, and an im-
pairment of £uid secretion in salivary glands is the etiology of
this condition. In order to cure of xerostomia, we have looked
for medical treatments which maintain persistently AQP5 in
the APM of salivary glands. We have now found that treat-
ment of the tissues with ( þ )-cis-2-methylspilo(1,3-oxathio-
lane-5,3P) quinuclidine (SNI-2011), which is a structurally rig-
id analog of ACh [11], induces a persistent increase in the
amount of AQP5 in the APM via long-lasting [Ca2]i oscil-
lations in the comparison with those of ACh in rat parotid
cells.
2. Materials and methods
2.1. Preparation and incubation of rat parotid tissues
Parotid gland slices (300 mg wet weight, 0.4 mm thick) were pre-
pared from male Wistar rats with a McIllwain Tissue Chopper
(Mickle Laboratory Engineering, Surrey, UK) and equilibrated with
Krebs^Ringer^Tris (KRT) solution (120 mM NaCl, 4.8 mM KCl,
1.2 mM KH2PO4, 1.2 mM MgSO4, 1.0 mM CaCl2, 16 mM Tris^
HCl (pH 7.4), 5 mM glucose) that had been gassed with O2 at
37‡C [12^14]. The slices were then incubated in 10 ml of fresh KRT
solution in the absence or presence of SNI-2011 or other agents.
2.2. Preparation of APM, BLM and ICM fractions from rat parotid
tissues
After the incubation, tissue slices were homogenized in 20 volumes
of ice-cold 5 mM HEPES^Tris (pH 7.5) containing 50 mM mannitol
and 0.25 mM MgCl2 (bu¡er 1) with a glass homogenizer and a Te£on
pestle. The homogenate was ¢ltered through a single layer of nylon
bolting cloth (150 mesh), and the ¢ltrate was used to prepare APM,
BLM and ICM fractions by the method of Longbottom and Van
Heyningen [15], with a slight modi¢cation [9]. Brie£y, the supernatant
obtained at 35 000Ug for 30 min at 4‡C was centrifuged at 200 000Ug
for 1 h to obtain ICMs. The pellet from 35 000Ug for 30 min at 4‡C
was suspended in bu¡er 1, followed by the addition of 1 M MgCl2 to
a ¢nal concentration of 10 mM and then left on ice for 30 min. The
suspension was centrifuged at 3000Ug for 15 min and the resultant
precipitate was used as BLMs. The resultant supernatant was again
centrifuged at 35 000Ug for 30 min to precipitate APMs. The activ-
ities of Q-glutamyltranspeptidase (Q-GT), as a marker of the APM,
and of K-stimulated p-nitrophenyl-phosphatase (KpNPPase), as a
marker of the BLM, were measured.
2.3. Measurement of [Ca2+]i in parotid acinar cells
Parotid acinar cells, which were prepared by collagenase/hyaluron-
idase digestion as previously described [16], were subjected to mea-
surement of [Ca2]i according to £uorescence study with fura-2/AM.
The cells were gently stirred in a cuvette maintained at 37‡C during
the assay. Changes in fura-2/AM £uorescence were monitored with a
£uorescence spectrometer (F-4000; Hitachi, Tokyo, Japan). The
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[Ca2]i was calculated from the ratio (340/380 nm) of £uorescence
intensities after subtraction of auto£uorescence, as described previ-
ously [16].
2.4. Immunoblot analysis
Rabbit polyclonal antibodies to AQP5 were generated in response
to a synthetic peptide (KGTYEPEEDWEDHREERKKTI) corre-
sponding to the deduced COOH-terminal amino acid sequence of
AQP5 [8]. APM, BLM and ICM fractions were subjected to sodium
dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^PAGE) on
12.5% gels, and the separated proteins were transferred electrophoreti-
cally to a nitrocellulose membrane. The blots were probed with anti-
AQP5 antibody (1:1500 dilution) and anti-Na/K-ATPase antibody
(1:50 dilution) (Chemicon, Temecula, CA, USA), or with the anti-
body that had been preadsorbed with excess synthetic peptide antigen.
Immune complexes were detected by enhanced chemiluminescence.
2.5. Measurement of inositol 1,4,5-trisphosphate (IP3) contents
The amount of IP3 in rat parotid tissues was measured with the
[3H]IP3 radioreceptor assay system (Du Pont NEN, Boston, MA,
USA). After incubation of tissue slices as described above, IP3 was
extracted from the slices (100 mg wet weight) by the method of Zhang
and Melvin [17]. Recovery from the entire extraction procedure was
s 90%.
2.6. Statistical analysis
Data are presented as means þ S.E.M. and were analyzed for sta-
tistical signi¢cance with Student’s t-test or analysis of variance.
P values of 6 0.05 were considered statistically signi¢cant.
3. Results
3.1. Isolation of rat parotid membranes
To ascertain the contamination in APM, ICM and BLM
fractions, Q-GT was used as a marker of the APM and
KpNPPase and Na/K-ATPase were as markers of the
BLM. The Q-GT activities in APMs, ICMs and BLMs were
375.0 þ 5.6, 18.3 þ 0.9 and 28.5 þ 2.7 nmol/min/mg protein, re-
spectively. The KpNPPase activities were 36.9 þ 3.6, 11.1 þ 1.2
and 61.8 þ 4.3 nmol/min/mg protein in APMs, ICMs and
BLMs, respectively. These fractions were then subjected to
SDS^PAGE and transferred to nitrocellulose membranes.
The blots were then probed with speci¢c anti-Na/K-ATP-
ase antibody. This antibody recognized a marked band with a
molecular mass of 45 kDa in BLMs, a weak band in ICMs
and no band in APMs (Fig. 1B). The densities of bands were
not changed even in APMs, ICMs and BLMs prepared from
tissues incubated with 10 WM SNI-2011. Thus, little of con-
taminating membranes in APMs and BLMs was determined
by the two independent procedures described above and SNI-
2011 did not a¡ect the membrane fractionation.
The immunoblot analysis with the antibody to AQP5 rec-
ognized a clear solitary band with a mobility corresponding to
the predicted molecular mass of AQP5 (27 kDa) in APMs and
ICMs but not in BLMs (Fig. 1A). The treatment of tissues
with 10 WM SNI-2011 increased the amount of AQP5 in
APMs (Fig. 1A).
3.2. E¡ect of SNI-2011 on the amount of AQP5
in the APM
The SNI-2011-induced increase in the amount of AQP5 in
the APM was concentration-dependent (Fig. 2); it was signi¢-
cant at 1 nM and maximal (301.8 þ 9.2% of control) at 10 WM,
with a median e¡ective concentration (EC50) value of
14.2 þ 2.3 nM, comparable to that for pilocarpine (9.0 þ 0.9
nM).
The SNI-2011-induced increase in the amount of AQP5 in
the APM was detectable at 1 min, maximal at 10 min, and still
signi¢cantly higher than that of control tissues after 30 min
(Fig. 3). The e¡ect of 10 WM pilocarpine was maximal at 3 min
and still apparent after 30 min. In contrast, the e¡ect of 10 WM
ACh on the amount of AQP5 was maximal at 15 s and was
no longer apparent after 10 min. Incubation of the tissue slices
with 10 WM SNI-2011 for 10 min induced a signi¢cant in-
crease in the amount of AQP5 in the APM and a correspond-
ing decrease in its amount in the ICM (Fig. 4). In the BLM,
the antibody to AQP5 did not recognize the expression of
AQP5 (Fig. 1A). These results suggest that the accumulation
Fig. 1. Distributions of AQP5 and Na/K-ATPase in the APM,
ICM and BLM of rat parotid glands. Parotid tissue slices were in-
cubated with (lanes 4^6) or without (lanes 1^3) 1035 M SNI-2011.
APMs, ICMs and BLMs (20 Wg of protein for AQP5 and 40 Wg of
protein for Na/K-ATPase) from rat parotid tissues were subjected
to immunoblot analysis with antibodies to AQP5 (A) and Na/K-
ATPase (B).
Fig. 2. E¡ects of various concentrations of SNI-2011 and pilocar-
pine on the amount of AQP5 in the APM. The APMs (5 Wg of pro-
tein) from parotid tissues incubated for 10 and 3 min with the indi-
cated concentrations of SNI-2011 or pilocarpine, respectively, were
subjected to immunoblot analysis with antibody to AQP5. The blots
were subjected to densitometric analysis, and the amount of AQP5
in the APMs was expressed as a percentage of the value for the tis-
sues incubated in the absence of the agents. Data are means
þ S.E.M. of 3^5 independent experiments. *P6 0.05, ***P6 0.001
versus the value for control cells. The lower inset shows the results
of a typical immunoblot of APMs of the tissues incubated with
SNI-2011 or pilocarpine at concentrations of 0, 1039, 1037, 1035, or
1033 M (lanes 1^5, respectively). The arrow is the position of
27 kDa.
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of AQP5 in the APM induced by SNI-2011 results from the
fusion of AQP5-containing ICM. The protein concentrations
in APM, BLM and ICM fractions from the parotid tissue
homogenate (23.3 þ 1.5 mg protein) were 0.089 þ 0.008,
1.54 þ 0.10 and 2.23 þ 0.04 mg protein, respectively, showing
that the yields of APM, BLM and ICM fractions were 0.4, 7
and 10%, respectively. Treatment of the tissues with SNI-2011
or pilocarpine did not a¡ect the yield of each fraction, nor did
it a¡ect immunoblot analysis per se.
Contrary to the ¢nding that ACh or epinephrine induces
the transient increase in the amount of AQP5 in the APM
[9,10], these ¢ndings show that SNI-2011 or pilocarpine in-
duces the long-lasting maintenance of AQP5 in the APM of
rat parotid glands.
3.3. E¡ects of atropine or hexahydro-sila-difenidol
(p-F-HHSiD) on the SNI-2011-induced increase in the
amount of AQP5 in the APM
As shown in Table 1, the SNI-2011-induced increase in the
abundance of AQP5 in the APM was prevented by 100 WM
atropine and 10 WM p-F-HHSiD. This result is consistent with
the observations that rat parotid glands express both M2 and
M3 AChRs [18], and that M3 AChRs constitute 90% of the
total number of precipitable AChR in the tissues [19]. The
interaction of SNI-2011 with M3 AChRs induces the long-
lasting maintenance of AQP5 in the APM of rat parotid
glands.
3.4. E¡ect of [Ca2+]i on the amount of AQP5 in the APM
Stimulation of M3 AChRs on salivary glands with their
respective agonists induces the generation of IP3 and diacyl-
glycerol ; the former induces the release of Ca2 from intra-
cellular stores and the latter activates protein kinase C (PKC)
[20,21]. Treatment of the tissues with either 300 WM H-7 or
10 WM bisindolmaleimide (GF 109203X), an inhibitor of
PKC, had no marked e¡ect on the amount of AQP5 in the
APM in the tissues stimulated by SNI-2011 (Table 1). Con-
versely, 1 WM phorbol 12-myristate 13-acetate (PMA), an ac-
tivator of PKC, did not induce an increase in the amount of
AQP5 in the APM (Table 1). These results suggest that the
SNI-2011-induced increase in the amount of AQP5 in the
APM is not mediated by the activation of PKC. Incubation
of the tissue slices with 30 WM 4,5-trimethoxy-benzoic 8-(di-
Fig. 3. Time courses for the e¡ects of SNI-2011, pilocarpine, and
ACh on the amount of AQP5 in the APM. The APMs (5 Wg of
protein) from parotid tissues incubated with SNI-2011 (10 WM), pi-
locarpine (10 WM), or ACh (10 WM) plus eserine (an inhibitor of
acetylcholine esterase) (10 WM) for 0, 0.25, 1, 3, 10, or 30 min (cor-
responding to lanes 1^6, respectively, in the inset) were subjected to
immunoblot analysis with antibody to AQP5. Data were quantitated
by densitometry and are means þ S.E.M. of 3^5 independent experi-
ments. **P6 0.01, ***P6 0.001 versus the value for control cells.
Table 1
E¡ects of various agents on the amount of AQP5 in the APM
Agent (WM) Relative amount of AQP5 (%)
None 100
SNI-2011 (10) 301.8 þ 9.2***
SNI-2011 (10)+atropine (100) 100.4 þ 5.1
SNI-2011 (10)+p-F-HHSiD (10) 141.1 þ 14.3
SNI-2011 (10)+U73122 (10) 95.6 þ 2.4
SNI-2011 (10)+TMB-8 (30) 94.9 þ 1.6
SNI-2011 (10)+dantrolene (30) 140.7 þ 9.6
SNI-2011 (10)+H-7 (300) 254.4 þ 4.8***
SNI-2011 (10)+GF 109203X (10) 305.0 þ 14.4***
PMA (1) 90.7 þ 3.9
The APMs (5 Wg of protein) from parotid tissues incubated for
10 min in the absence or presence of the indicated agents were sub-
jected to immunoblot analysis with antibody to AQP5. The amount
of AQP5 in the APM was quantitated by densitometry and ex-
pressed as described in the legend for Fig. 2. Data are means
þ S.E.M. of 3^6 independent experiments. Signi¢cantly di¡erent
from the control value, ***P6 0.001.
Fig. 4. E¡ect of SNI-2011 on the amount of AQP5 in the APM
and the ICM. A: APMs (5 Wg of protein) and ICMs (40 Wg of pro-
tein) from parotid tissues incubated in the absence (C) or presence
(SNI-2011) of 10 WM SNI-2011 for 10 min were subjected to immu-
noblot analysis with antibodies to AQP5. B: Immunoblots shown in
A were subjected to densitometric analysis, and the amount of
AQP5 in each fraction was expressed as % of total amount (the
amount of AQP5 in APMs plus that in ICMs) of AQP5. Data are
means þ S.E.M. of three independent experiments. **P6 0.01,
***P6 0.001 versus the value for control cells.
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ethylamino) octylester (TMB-8), an inhibitor of calcium re-
lease from intracellular stores, prevented the increase in the
amount of AQP5 in the APM induced by SNI-2011 (Table 1),
indicating that the elevation of [Ca2]i associated with the
activation of M3 AChRs by SNI-2011 contributes to the e¡ect
on the amount of AQP5. 1-6-[6-[[(17L)-3-Methoxyestra-1,3,5-
(10)-trien-17-yl]-amino]hexyl-1H-10ymole-2,5-dione] (U73122)
completely inhibited the SNI-2011-induced increase in the
amount of AQP5 in the APM at a concentration of 10 WM
that blocked phosphoinositide hydrolysis by phospholipase C
(PLC) and the generation of IP3 (Table 1). In general, IP3-
gated channels might release Ca2 which would in turn induce
Ca2 release from the Ca2-induced Ca2 release pathway
through ryanodine receptors (RyRs) [22]. Treatment of rat
parotid tissue slices with 30 WM dantrolene, which prevents
the release of Ca2 from IP3-insensitive stores, inhibited the
SNI-2011-induced increase in the amount of AQP5 in the
APM by 80% (Table 1).
Taken together, these results indicate that the SNI-2011-
induced increase in the amount of AQP5 in the APM is medi-
ated by an increase in [Ca2]i that results from Ca2 release
from intracellular stores through two distinct classes of recep-
tors, IP3 receptors and RyRs, but not by the activation of
PKC.
3.5. E¡ect of SNI-2011 on the generation of IP3
Incubation of the tissues with SNI-2011 caused an increase
in the intracellular amount of IP3 ; this e¡ect was maximal at
10 min (3.20 þ 0.07 and 9.16 þ 1.42 pmol/mg protein in the
control and SNI-2011-treated tissues, respectively) and re-
mained apparent at 30 min (3.48 þ 0.34 and 5.78 þ 0.92
pmol/mg protein in the control and SNI-2011-treated tissues,
respectively). The tissues stimulated by ACh generated IP3
with a maximum at 15 s (3.89 þ 0.02 and 16.9 þ 2.2 pmol/mg
protein in the control and ACh-treated tissues, respectively).
These data suggest that the increase in the generation of IP3
by SNI-2011 triggers the increase in the amount of AQP5 in
the APM.
3.6. E¡ect of SNI-2011 on the oscillation of [Ca2+]i in isolated
parotid cells
To determine whether SNI-2011 mobilizes Ca2 from intra-
cellular pools, we loaded isolated parotid cells with fura-2/AM
and then exposed them to 10 WM SNI-2011 in the absence or
presence of 1 mM CaCl2. SNI-2011 induced the generation of
marked oscillations of [Ca2]i that persisted for longer than
30 min in the presence of extracellular CaCl2 (Fig. 5).
Although SNI-2011 also induced [Ca2]i oscillations in cells
incubated in Ca2-free medium, both the [Ca2]i and the am-
plitude of the oscillations were greatly reduced in comparison
with those apparent in cells incubated in Ca2-containing me-
dium; the oscillations were also no longer detected after 6 min
of the incubation. These results demonstrate that SNI-2011
mobilizes Ca2 from intracellular stores and leads to the in-
duction of a persistent increase in the amount of AQP5 in the
APM.
4. Discussion
With the use of an AQP5-speci¢c antiserum, we have now
shown that SNI-2011 acting at M3 AChRs induces a long-
lasting increase in the amount of AQP5 in the APM in rat
parotid glands (Fig. 3, Table 1). The long-lasting increase in
the abundance of AQP5 in the APM induced by SNI-2011
was accompanied by a corresponding decrease in the amount
of AQP5 associated with the ICM (Fig. 4). Intravenous ad-
ministration of SNI-2011 induces long-lasting salivary secre-
tion in rats and dogs [23]. Although the site of action of SNI-
2011 on the long-lasting salivation had not been clear, we
demonstrated that the increase in the amount of AQP5 in
the APM of rat parotid glands participated in SNI-2011-in-
duced salivation.
Recently, attention has been focused on the role of AQPs in
each membrane fraction [1^3,9,10,24^26]. Several papers re-
ported that the amount of AQP5 in the APM was regulated
by neurotransmitters in salivary glands [9,10,26]. The expo-
sure of rat parotid tissues to ACh or epinephrine induced
increases in the amount of AQP5 in the APM [9,10]. Con-
versely, the treatment of parotid gland cells with L-adrenergic
agonists resulted in the dispersal of AQP5 immunoreactivity
as clusters of dots in submembranous cytoplasmic areas [26].
The ACh- or epinephrine-induced increase in the amount of
AQP5 was no longer apparent after 10 min. In contrast, the
e¡ects of SNI-2011 and pilocarpine on the amount of AQP5
in the APM were maximal at 10 and 3 min, respectively, and
were still apparent at 30 min (Fig. 2). Although the maximal
amount of AQP5 in the APM of the tissues treated with SNI-
2011 was 70% of that for the tissues exposed to ACh (Fig. 2),
the most marked di¡erence between the e¡ects of the full and
partial muscarinic agonists was in the duration of the re-
sponse.
Treatment of the tissues with U73122, TMB-8 or dantro-
lene completely inhibited the SNI-2011-induced increase in the
amount of AQP5 in the APM (Table 1). These observations
indicate that the interaction of SNI-2011 with M3 AChRs
activates PLC and subsequently increases the release of
Ca2 from intracellular stores via the activation of IP3 recep-
tors and RyRs. It has been proposed that an initial release of
Ca2 from the IP3-sensitive pool acts as a primer for further
Ca2 release from the Ry-sensitive pool producing oscillations
[22]. The characteristics of [Ca2]i oscillations generated by
Fig. 5. E¡ect of SNI-2011 on [Ca2]i in rat parotid acinar cells. Iso-
lated acinar cells were loaded with fura-2/AM and then exposed to
10 WM SNI-2011 in the presence (A) or absence (B) of 1 mM
CaCl2. The [Ca2]i was calculated from £uorescence measurements
as described in Section 2. SNI-2011 was added at the time indicated
by the arrow.
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full muscarinic agonists di¡er from those induced by partial
agonists. ACh evoked a transient elevation of [Ca2]i lasting
about 2^5 min [27]. Furthermore, the concentration of IP3 is
four-fold higher than that of control at 15 s after addition of
ACh. In contrast, it is three-fold higher than that of control at
10 min after the addition of SNI-2011 (Fig. 5).
Collectively, these results indicate that SNI-2011 acting at
M3 AChRs in rat parotid acinar cells induces persistent oscil-
lations of [Ca2]i and leads to long-lasting increases in the
amount of AQP5 in the APM.
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